TMCI

Treace Medical Concepts, Inc. (NASDAQ:TMCI) is a specialized orthopedic medical device company founded in 2013 and headquartered in Ponte Vedra Beach, Florida. The company went public in April 2021 and focuses exclusively on developing, manufacturing, and marketing innovative surgical solutions for foot and ankle procedures, particularly bunion correction surgeries. Since its founding, Treace has established itself as a pioneer in three-dimensional bunion correction technology, moving beyond traditional two-dimensional approaches that had dominated the field for decades. The company has treated over 130,000 patients through its network of more than 3,100 trained surgeons across the United States.